Raziel Arturo Jiménez-Nava

Dr. Raziel Arturo Jiménez-Nava

Instituto Politécnico Nacional, Mexico City, Ciudad de México, Mexico
orcid
Currently working with diverse yeast species to improve the ...

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GCGriselda Ma. Chávez–Camarillo
Griselda Ma. Chávez–Camarillo
PLPerla Vianey Lopez-Nuñez
Perla Vianey Lopez-Nuñez
Raziel Arturo Jiménez-NavaRaziel Arturo Jiménez-Nava
Raziel Arturo Jiménez-Nava
EAErick Aranda-García
Erick Aranda-García
Eliseo Cristiani-UrbinaEliseo Cristiani-Urbina
Eliseo Cristiani-Urbina
The kinetics of growth and α-amylase production of a novel Candida wangnamkhiaoensis yeast strain were studied in single-stage steady-state continuous cultures. This was performed in a split-cylinder internal-loop airlift bioreactor, using a variety of carbon sources as fermentation substrates. Results showed that the steady-state yields of cell mass from carbohydrates were practically constant for the range of dilution rates assayed, equaling 0.535 ± 0.030, 0.456 ± 0.033, and 0.491 ± 0.035 g biomass/g carbohydrate, when glucose, maltose, and starch, respectively were used as carbon sources. No α-amylase activity was detected when glucose was used as the carbon source in the influent medium, indicating that α-amylase synthesis of C. wangnamkhiaoensis is catabolically repressed by glucose. Contrastingly, maltose and starch induce synthesis of α-amylase in C. wangnamkhiaoensis, with starch being the best α-amylase inducer. The highest α-amylase volumetric and specific activities (58400 ± 800 U/L and 16900 ± 200 U/g biomass, respectively), and productivities (14000 ± 200 U/L·h and 4050 ± 60 U/g biomass·h, respectively) were achieved at a dilution rate of 0.24 h-1 using starch as the carbon source. In conclusion, single-stage steady-state continuous culture in an airlift bioreactor represents a powerful tool, both for studying the regulatory mechanisms of α-amylase synthesis by C. wangnamkhiaoensis and for α-amylase production. Furthermore, results showed that C. wangnamkhiaoensis represents a potential yeast species for the biotechnological production of α-amylase, which can be used for the saccharification of starch. This offers an attractive renewable resource for the production of biofuels (particularly bioethanol), representing an alternative to fossil fuels with reduced cost of substrates.

20 September 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
Raziel Arturo Jiménez-NavaRaziel Arturo Jiménez-Nava
Raziel Arturo Jiménez-Nava
LZLuis Gerardo Zepeda-Vallejo
Luis Gerardo Zepeda-Vallejo
FSFortunata Santoyo-Tepole
Fortunata Santoyo-Tepole
GCGriselda Ma. Chávez–Camarillo
Griselda Ma. Chávez–Camarillo
Eliseo Cristiani-UrbinaEliseo Cristiani-Urbina
Eliseo Cristiani-Urbina
The yeast Hyphopichia wangnamkhiaoensis excretes a brilliant yellow fluorescent compound into its growth culture. In this study, we isolated and identified this compound using reverse-phase high-performance liquid chromatography-diode array detector (RP-HPLC-DAD) as well as 1H NMR and UV–Vis spectroscopy. Two of the three RP-HPLC-DAD methods used successfully separated the fluorescent compound and involved (1) a double separation step with isocratic flow elution, first on a C18 column and later on a cyano column, and (2) a separation with a linear gradient elution on a phenyl column. The wavelengths of maximum absorption of the fluorescent compound-containing HPLC fractions (~224, 268, 372, and 446 nm) are in good agreement with those exhibited by flavins. The 1H NMR spectra revealed methyl (δ 2.30 and 2.40) and aromatic proton (δ 7.79 and 7.77) signals of riboflavin. The 1H NMR spectra of the samples spiked with riboflavin confirmed that the brilliant yellow fluorescent compound is riboflavin. The maximum excitation and emission wavelengths of the fluorescent compound were 448 and 528 nm, respectively, which are identical to those of riboflavin.

Verified
Journal Article
Open access
PDF file
Raziel Arturo Jiménez-NavaRaziel Arturo Jiménez-Nava
Raziel Arturo Jiménez-Nava
GCGriselda Ma. Chávez–Camarillo
Griselda Ma. Chávez–Camarillo
Eliseo Cristiani-UrbinaEliseo Cristiani-Urbina
Eliseo Cristiani-Urbina
Riboflavin, an essential vitamin for humans, is extensively used in various industries, with its global demand being met through fermentative processes. Hyphopichia wangnamkhiaoensis is a novel dimorphic yeast species capable of producing riboflavin. However, the nutritional factors affecting riboflavin production in this yeast species remain unknown. Therefore, we conducted a kinetic study on the effects of various nutritional factors—carbon and energy sources, nitrogen sources, vitamins, and amino acids—on batch riboflavin production by H. wangnamkhiaoensis. Batch experiments were performed in a bubble column bioreactor to evaluate cell growth, substrate consumption, and riboflavin production. The highest riboflavin production was obtained when the yeast growth medium was supplemented with glucose, ammonium sulfate, biotin, and glycine. Using these chemical components, along with the mineral salts from Castañeda-Agullo’s culture medium, we formulated a novel, low-cost, and effective culture medium (the RGE medium) for riboflavin production by H. wangnamkhiaoensis. This medium resulted in the highest levels of riboflavin production and volumetric productivity, reaching 16.68 mg/L and 0.713 mg/L·h, respectively, within 21 h of incubation. These findings suggest that H. wangnamkhiaoensis, with its shorter incubation time, could improve the efficiency and cost-effectiveness of industrial riboflavin production, paving the way for more sustainable production methods.

2 February 2026 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
Raziel Arturo Jiménez-NavaRaziel Arturo Jiménez-Nava
Raziel Arturo Jiménez-Nava
GCGriselda Ma. Chávez-Camarillo
Griselda Ma. Chávez-Camarillo
Eliseo Cristiani-UrbinaEliseo Cristiani-Urbina
Eliseo Cristiani-Urbina

3 April 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Raziel Arturo Jiménez-NavaRaziel Arturo Jiménez-Nava
Raziel Arturo Jiménez-Nava
GCGriselda Ma. Chávez-Camarillo
Griselda Ma. Chávez-Camarillo
Eliseo Cristiani-UrbinaEliseo Cristiani-Urbina
Eliseo Cristiani-Urbina
Riboflavin is biosynthesized and excreted extracellularly by the novel yeast Hyphopichia wangnamkhiaoensis. The steady-state kinetics of cell growth, substrate consumption, and riboflavin production by H. wangnamkhiaoensis were studied in a chemostat continuous culture at different dilution rates. The unstructured Monod and Luedeking–Piret models were used to describe cell growth, substrate consumption, and riboflavin production, and crucial kinetic parameters were estimated. The experimental data fitted the proposed models well. The maximum specific growth rate, substrate affinity constant, maintenance energy coefficient, and maximum biomass yield values were 0.1378 h−1, 0.4166 g of glucose L−1, 0.1047 g of glucose g−1 of biomass h−1, and 0.172 g of biomass g−1 of glucose, respectively. The maximum yield from glucose and volumetric and specific productivities of riboflavin were 0.7487 mg of riboflavin g−1 of glucose, 0.5593 mg of riboflavin L−1 h−1, and 0.6547 mg of riboflavin g−1 of biomass h−1, respectively. The estimated growth-associated riboflavin production constant (4.88 mg of riboflavin g−1 of biomass) was much higher than the non-growth-associated riboflavin production constant (0.0022 mg of riboflavin g−1 of biomass h−1), indicating that riboflavin production by H. wangnamkhiaoensis is a predominantly growth-associated process. The chemostat continuous culture offers a promising strategy for efficiently and sustainably producing riboflavin using H. wangnamkhiaoensis.

28 February 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Raziel Arturo Jiménez-NavaRaziel Arturo Jiménez-Nava
Raziel Arturo Jiménez-Nava
GCGriselda Ma. Chávez-Camarillo
Griselda Ma. Chávez-Camarillo
Eliseo Cristiani-UrbinaEliseo Cristiani-Urbina
Eliseo Cristiani-Urbina
Riboflavin (RF; vitamin B2) is an essential micronutrient with broad applications in the food, feed, pharmaceutical, and cosmetic industries and is increasingly relevant in bioelectrochemical systems and environmental biotechnology. Microbial fermentation has replaced chemical synthesis as the dominant industrial production route due to its superior sustainability and scalability. However, despite substantial progress, RF biosynthesis remains constrained by imbalances in precursor supply, complex redox regulation, and regulatory feedback mechanisms that limit metabolic flux toward guanosine triphosphate and ribulose-5-phosphate. This review provides an updated, integrative analysis of RF biotechnology, encompassing biosynthetic pathways, transcriptional and redox-regulation, strain improvement strategies, and fermentation process optimization. Representative industrial producers—including Bacillus subtilis, Ashbya gossypii, and Candida famata—are critically evaluated for productivity, yield, and metabolic robustness, with reported titers reaching up to 29 g L−1 in engineered systems. Emerging microbial platforms, including lactic acid bacteria, thermotolerant and methylotrophic microorganisms, and electroactive bacteria, are discussed in the context of niche applications such as food biofortification and microbial fuel cells. Special emphasis is placed on oxidative stress as a regulatory signal influencing RF overproduction, metabolic rewiring strategies to alleviate precursor bottlenecks, and the biosynthesis of RF derivatives (FMN, FAD, roseoflavin, and 8-aminoriboflavin). In addition, biosafety, regulatory constraints, concerns about genome stability, and antibiotic-free engineering approaches are examined as critical determinants of future industrial competitiveness. By integrating molecular regulation, metabolic engineering, fermentation design, emerging applications, and regulatory perspectives within a unified framework, this review outlines current bottlenecks and future directions for developing safer, more robust, and economically competitive RF-producing microbial platforms.